Autoradiographic distribution of M1, M2, M3, and m4 muscarinic receptor subtypes in Alzheimer's disease

Synapse

Volumn 26, Issue 4, 1997, Pages 341-350

  Rodríguez Puertas, Rafael ^a   Pascual, Julio ^a,b   Vilaró, Teresa ^c   Pazos, Ángel ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c INST D INVESTIGACIONS B   (Spain)

Author keywords

Alzheimer's disease; M1 muscarinic receptors; M2 muscarinic receptors; M3 muscarinic receptors; M4 muscarinic receptors; Muscarinic receptors; Quantitative receptor autoradiography

Indexed keywords

MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC RECEPTOR; RECEPTOR SUBTYPE;

ALZHEIMER DISEASE; ARTICLE; AUTORADIOGRAPHY; BRAIN BIOPSY; DOPAMINERGIC NERVE CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; NERVE DEGENERATION; PRIORITY JOURNAL; TISSUE DISTRIBUTION; VISUAL CORTEX;

AGED; ALZHEIMER DISEASE; AUTORADIOGRAPHY; BRAIN; BRAIN CHEMISTRY; FEMALE; HUMANS; LIGANDS; MALE; MIDDLE AGED; RECEPTORS, MUSCARINIC;

EID: 1842407763     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199708)26:4<341::AID-SYN2>3.0.CO;2-6     Document Type: Article

References (89)

1. American Psychiatric Association, Committee on Nomenclature and Statistics (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., revised. American Psychiatric Association, Washington, DC.
2. Araujo, D.M., Lapchack, P.A., Robitaille, Y., Gauthier, S., and Quirion, R. (1988) Differential alterations of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. J. Neurochem., 50:1214-1223.
3. 3H]4-DAMP to muscarinic cholinergic sites in the rat brain: evidence from membrane binding and autoradiographic studies. Synapse, 9:65-176.
4. Aubert, I., Araujo, D.M., Cécyre, D., Robitaille, Y., Gauthier, S., and Quirion, R. (1992a) Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. J. Neurochem., 58:529-541.
5. 3H] AF-DX384 binding to putative muscarinic M2 receptors in the rat brain. Eur. J. Pharmacol., 217:173-184.
6. Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K., and Seitelberger, F. (1973) Brain dopamine and the syndromes of Parkinson and Huntington: clinical, morphological and neurochemical correlations. J. Neurol. Sci., 20:415-455.
7. Bonner, T.I. (1989) The molecular basis of muscarinic receptors. Trends Neurosci., 12:149-151.
8. Braak, H., and Braak, E. (1991) Neuropathological staging of Alzheimer related changes. Acta Neuropathol., 82:239-259.
9. Buckley, N.J., Bonner, T.I., and Brann, M.R. (1989) Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol. Pharmacol., 35:469-476.
10. Caulfield, M.P., Straughan, D.W., Cross, A.J., Crow, T., and Birdsall, N.J.M. (1982) Cortical muscarinic receptor subtypes and Alzheimer's disease. Lancet, 2:1277.
11. Cortés, R., Probst, A., and Palacios, J.M. (1984) Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: brainstem. Neuroscience, 12:1003-1026.
12. Cortés, R., Probst, A., Tobler, H.J., and Palacios, J.M. (1986) Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies. Brain Res., 362:239-253.
13. Coyle, J.T., Price, D.L., and De Long, M.R. (1983) Alzheimer's disease: a disorder of cortical cholinergic innervation. Science, 219:1185-1190.
14. Cross, R.B. (1983) Demostration of neurofibrillary tangles in paraffin sections: a quick and simple method using a modification of Palmgren's method. Med. Lab. Sci., 39:67-69.
15. Davies, P. (1979) Neurotransmitter-related enzymes in senile dementia of Alzheimer type. Brain Res., 171:319-327.
16. Davies, P., and Maloney, A.J.F. (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet, 2:1403.
17. Davies, P., and Verth, A.H. (1978) Regional distribution of muscarinic acetylcholine receptors in normal and Alzheimer's type dementia brains. Brain Res., 138:385-392.
18. Dekosky, S., Harbaugh, E.R., Schmit, A.F., Bakay, A.E., Chui, C.H., Knopman, S.D., Reeder, M.T., Senter, J.H., Markersberr, R.W., and the Intraventricular Bethanecol Study Group. (1992) Cortical biopsy in Alzheimer's disease - diagnostic accuracy and neurochemical, neuropathological and cognitive correlations. Ann. Neurol., 32:625-632.
19. Ditter, S.M., and Mirra, S.S. (1987) Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology, 37:754-760.
20. Dörje, F., Wess, J., Lambrecht, G., Tacke, R., Mustchler, E., and Brann, M.R. (1991) Antagonist binding profiles of five cloned human brain muscarinic receptor subtypes. J. Pharmacol. Exp. Ther., 256:727-733.
21. 2 hydrolysis in Alzheimer's disease. Life Sci., 53:PL439-444.
22. Ferrari-DiLeo, G., Waelbroeck, M., Mash, D.C., and Flynn, D.D. (1994) Selective labeling and localization of the M4 (m4) muscarinic receptor subtype. Mol. Pharmacol., 46:1028-1035.
23. Ferrari-Di Leo, G., Mash, D.C., and Flynn, D.D. (1995) Attenuation of muscarinic receptor-G protein interaction in Alzheimer's disease. Mol. Chem. Neuropathol., 24:69-91.
24. Fibiger, H.C. (1991) Cholinergic mechanisms in learning, memory and dementia: a review of the recent evidence. Trends Neurosci., 14:220-223.
25. 3H-nicotine binding in human brain cerebral cortex: comparison between Alzheimer's disease and normal. J. Neurochem., 29:256-262.
26. 3H]-Methylscopolamine afford differential labelling and localization of M1, M2 and M3 muscarinic receptor subtypes in primate brain. Synapse, 14:283-296.
27. Flynn, D.D., Weinstein, D.A., and Mash, D.C. (1991) Loss of high affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies. Ann. Neurol., 29:256-262.
28. Flynn, D.D., Ferrari-DiLeo, G., Mash, D.C., and Levey, A.I. (1995) Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease. J. Neurochem., 64:1888-1891.
29. 3H]hemicholinium-3 as a quantitative marker. J. Neurochem., 60:1191-1201.
30. Höhmann, C., Antouno, P., and Coyle, J.T. (1988) Basal forebrain neurons and Alzheimer's disease. In: Handbook of Psychopharmacology: Psychopharmacology of the Aging Nervous System. S.D. Iversen, S.H. Iversen, and S.H. Snyder, eds. Plenum Press, New York, pp. 69-106.
31. Hung, A.Y., Haass, C., Nitsch, R.M., Qiu, W.Q., Citron, M., Wurtman, R.J., Growdon, J.H., and Selkoe, D.J. (1993) Activation of protein kinase C inhibits cellular production of the amyloid β-protein. J. Biol. Chem., 268:22959-22962.
32. Jeni-Einermann, S., Von-Hahn, H.P., Honegger, C.G., and Ulrich, J. (1984) Studies on neurotransmitter binding in senile dementia. Gerontology, 30:350-358.
33. Kellar, K.J., Whitehouse, P.J., Martino-Barrows, A.M., Marcus, K., and Price, D.L. (1987) Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease. Brain Res., 436:62-68.
34. Khachaturian, Z.S. (1985) Diagnosis of Alzheimer's disease. Arch. Neurol., 42:1097-1104.
35. Lang, W., and Henke, H. (1983) Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients. Brain Res., 267:271-280.
36. Lange, K.W., Wells, F.R., Jenner, P., and Marsden, C.D. (1989) Brain muscarinic receptors in Alzheimer's disease and Parkinson's disease. Lancet, 1:1279.
37. Mash, D.L., Flynn, D.D., and Potter, L.T. (1985) Loss of M2 muscarinic receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science, 228:115-117.
38. 2+ homeostasis in Alzheimer's disease. Trends Neurosci., 16:409-414.
39. McGeer, P.L., McGeer, E.G., Suzuki, J., Dolman, C.E., and Nagai, T. (1984) Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain. Neurology, 34:741-745.
40. McKahn, G., Drachmanm, D., Folstein, M., Katzman, R., Price, D., and Stadlan, E.M. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology, 39:939-944.
41. McKinney, M., Miller, J.H., and Aagaard, P.J. (1993) Pharmacological characterization of the rat hippocampal muscarinic autoreceptor. J. Pharmacol. Exp. Ther., 264:74-78.
42. 3H]4DAMP. Eur. J. Pharmacol., 166:459-466.
43. Nitsch, M.N., Slack, B.E., Wurtman, R.J., and Growdon, J.H. (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258:304-307.
44. Nordberg, A., Larsson, C., Adolfsson, R., Alafuzoff, I., and Winblad, B. (1983) Muscarinic receptor compensation in hippocampus of Alzheimer patients. J. Neural. Transm., 56:13-19.
45. Nordberg, A., Alafuzoff, I., and Winblad, B. (1986) Muscarinic receptor subtypes in hippocampus in Alzheimer's disease and mixed dementia type. Neurosci. Lett., 70:160-164.
46. Nordberg, A., Alafuzoff, I., and Winblad, B. (1992) Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia. J. Neurosci. Res., 31:103-111.
47. Palacios, J.M. (1982) Autoradiographic localization of muscarinic cholinergic receptors in the hippocampus of patients with senile dementia. Brain Res., 243:173-175.
48. 3H]hemicholinium-3 binding sites in human brain Brain Res., 505:306-310.
49. 3H]hemicholinium-3 binding sites in human brain membranes: a marker for presynaptic cholinergic nerve terminals. J. Neurochem., 54:792-800.
50. Pascual, J., Fontán, A., Zarranz, J.J., Berciano, J., Flórez, J., and Pazos, A. (1991) High-affinity choline uptake carrier in Alzheimer's disease: implications for the cholinergic hypothesis of dementia. Brain Res., 552:170-174.
51. Perry, E.K. (1986) The cholinergic hypothesis-ten years on. Br. Med. Bull., 42:63-69.
52. Perry, E.K., Gibson, P.H., Blessed, G., Perry, R.H., and Tomlinson, B.E. (1977) Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J. Neurol. Sci., 34:247-265.
53. Perry, E.K., Tomlinson, B.E., Blessed, G., Bergmann, K., Gibson, P.H., and Perry, R.H. (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. Med. J., 2:1457-1459.
54. Perry, E.K., Perry, E.H., Smith, C.J., Dick, D.J., Candy, J.M., Edwardson, J.A., Fairbairn, A., and Blessed, G. (1987a) Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases. J. Neurol. Neurosurg. Psychiatry, 50:806-809.
55. Perry, E.K., Perry, R.H., Smith, C.J., Purohit, D., Bonham, J., Dick, D.J., Candy, J.M., Edwardson, J.A., and Fairbairn, A. (1987b) Cholinergic receptors in cognitive disorders. Can. J. Neurol. Sci., 13:521-527.
56. Perry, E.K., Smith, C.J., Court, J.A., and Perry, R.H. (1990) Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types. J. Neural Transm., 2:149-158.
57. Perry, E.K., Morris, C.M., Court, J.A., Cheng, A., Fairbairn, A.F., McKeith, I.G., Irving, D., Brown, A., and Perry, R.H. (1995) Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease. Neuroscience, 64:385-395.
58. Probst, A., Cortes, R., Ulrich, J., and Palacios, J.M. (1988) Differential modifications of cholinergic receptors in the hippocampus of patients with Alzheimer's disease: an autoradiographic study. Brain Res., 450:190-201.
59. Quirion, R., Martel, J.C., Robitaille, Y., Etiene, P., Wood, P., Nair, N.P.V., and Gauthier, S. (1986) Neurotransmitter and receptor deficits in senile dementia of Alzheimer's type. Can. J. Neurol. Sci., 13:503-510.
60. 3H]acetylcholine muscarinic receptors in mammalian brain. Apparent labelling of an M2-like receptor subtype. Neuroscience, 2:271-289.
61. Reinikanien, K.J., Riekkinen, P.J., Halonen, T., and Laakso, M. (1987) Decreased muscarinic receptor binding in cerebral cortex and hippocampus in Alzheimer's disease. Life Sci., 41:335-344.
62. Reisine, T.D., Yamamura, H.I., Bird, E.D., and Enna, S.J. (1978) Pre and postsynaptic neurochemical alternatives in Alzheimer's disease. Brain Res., 159:477-481.
63. Rinne, J.O., Laakso, K., Lonnberg, P., Molsa, P., Paljarvi, L., Rinne, J.K., Sako, E., and Rinne, U.K. (1985) Brain muscarinic receptors in senile dementia. Brain Res., 336:19-25.
64. Rinne, J.O., Lonnberg, P., Marjamaki, P., and Rinne, U.K. (1989) Brain muscarinic receptor subtypes are differentially affected in Alzheimer's and Parkinson's disease. Brain Res., 483:402-406.
65. Rinne, J.O., Myllylilla, T., Lonnberg, P., and Marjamaki, P. (1991) A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's diseases. Brain Res., 547:167-170.
66. 3H]hemicholinium-3. J. Neural. Transm. Park. Dem. Sect., 8:161-169.
67. Rodríguez-Puertas, R., Pascual, J., and Pazos, A. (1996) Effects of freezing storage time on the density of muscarinic receptors in the human postmortem brain: an autoradiographic study in control and Alzheimer's disease brain tissues. Brain Res., 728:65-71.
68. Russo, C., Marchi, M., Andrioli, G.C., Cavazzani, P., and Raitieri, M. (1993) Enhancement of glycine release from human brain cortex synaptosomes by acetylcholine acting at M4 muscarinic receptors. J. Pharmacol. Exp. Ther., 266:142-146.
69. Shimohama, S., Taniguchi, T., Fujiwara, M., and Kameyama, M. (1986) Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia. J. Neurochem., 46:288-293.
70. Shimohama, S., and Matsushima, H. (1995) Signal transduction mechanisms in Alzheimer's disease. Alzheimer's Dis. Assoc. Dis., 9 (suppl. 2):15-22.
71. Slotkin, T.A., Seidler, F.J., Crin, B.J., Bell, J.M., Bissette, G., and Nemeroff, C.B. (1990) Regulatory changes in presynaptic cholinergic function assessed in rapid autopsy material from patients with Alzheimer disease: implications for etiology and therapy. Proc. Natl. Acad. Sci. USA, 87:2452-2455.
72. Slotkin, T.A., Nemeroff, C.B., Bissette, G., and Seidler, F.J. (1994) Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer disease. Evidence from rapid autopsy studies. J. Clin. Invest., 94:696-702.
73. Spencer, D.G., Horvath, E., and Traber, J. (1986) Direct autoradiographic determination of M1 and M2 muscarinic acetylcholine receptor distribution in the rat brain: relation to cholinergic nuclei and projections. Brain Res., 380:59-68.
74. Svensson, A.L., Alafuzoff, I., and Nordberg, A. (1992) Characterization of muscarinic receptor subtypes in Alzheimer's disease and control brain cortices by selective muscarinic antagonists. Brain Res., 596:142-148.
75. Thai, L.J. (1994) Clinical trials in Alzheimer disease. In: Alzheimer Disease. R.D. Terry, R. Katzman, K.L. Bick, eds. Raven Press, New York, pp. 431-444.
76. Vanderheyden, P., Ebinger, G., Dierckx, R., and Vauquelin, G. (1987) Muscarinic cholinergic receptor subtypes in normal human brain and Alzheimer's presenile dementia. J. Neurol. Sci., 82:257-269.
77. Viana, G.S.B., Miranda, D.C., Bruin, V.M.S., Costa, C.M.C., and Bruno, J.A. (1991) Muscarinic cholinergic receptors and acetylcholinesterase activity in brain of patients with dementia. J. Med. Biol. Res., 24:43-47.
78. Vilaró, M.T., Wiederhold, K.H., Palacios, J.M., and Mengod, G. (1992) Muscarinic M2-selective ligands also recognize M4 receptors in the rat brain: evidence from combined in situ hybrydization and receptor autoradiography. Synapse, 11:171-183.
79. Vilaró, M.T., Mengod, G., and Palacios, J.M. (1993). Advances and limitations of the molecular neuroanatomy cholinergic receptors: the example of multiple muscarinic receptors. In Progress in Brain Research, vol. 98. A.C. Cuello, ed. Elsevier, Amsterdam, pp. 95-101.
80. 3H]N-metylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites. Mol. Pharmacol. 30:305-314.
81. Waelbroeck, M., Tastenoy, M., Camus, J., and Cristophe, J. (1990) Binding of selective antagonist for four muscarinic receptors (M1 to M4) in rat forebrain. Mol. Pharmacol., 38:267-273.
82. 3H]AFDX 116. Mol. Brain Res., 16:64-70.
83. Weines, K., and Warburton, D.M. (1984) Effects of scopolamine and nicotine in human rapid information processing performance. Psychopharmacology, 82:147-150.
84. White, P., Goodhardt, M.J., Keet, J.P., Hiley, C.R., Carrasco, L.H., Williams, I.E.I., and Bowen, D.M. (1977) Neocortical cholinergic neurons in elderly people. Lancet, 1:668-670.
85. Whitehouse, P.J., Price, D.I,. Clark, A.W., Coyle, T.T., and De Long, M. (1981) Alzheimer's disease: evidence for a selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol., 10:122-126.
86. Whitehouse, P.J., Price, D.L., Struble, R.G., Clark, A.W., Coyle, J.T., and De Long, M.R. (1982) Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science, 215:1237-1239.
87. Whitehouse, P.J., Martino, A.M., Antuono, P.O., Lowenstein, P.R., Coyle, J.T., Price, D.L., and Kellar, K.K. (1986) Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res., 371:146-151.
88. 3H]nicotine acetylcholine binding in Alzheimer's disease and Parkinson's disease: an auturadiographic study. Neurology, 38:720-723.
89. Wood, P.L., Etienne, P., Lal, S., Nair, N.P.M., Finlayson, M.H., Gauthier, S., Palo, J., Haltia, M., Paetau, A., and Bird, E.D. (1983) A postmortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick disease. J. Neurol. Sci., 62:211-217.